Wockhardt Ltd
Wockhardt Ltd (WOCKPHARMA) last traded at ₹1,894, a market capitalisation of ₹30,777 crore, on a P/E of 77.2. Over the past 52 weeks the stock has ranged between ₹1,087 and ₹2,422. Wockhardt Ltd last reported results for the quarter ended Jun 2026, with sales of ₹929 crore and net profit of ₹107 crore. Figures are as of 25 Aug 2026 and are not real time.
Wockhardt Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Wockhardt Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹929 cr, up 25.9% from ₹738 cr a year earlier. Net profit turned positive at ₹107 cr.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 809 | 721 | 743 | 738 | 782 | 888 | 965 | 929 |
| Expenses | 699 | 593 | 679 | 666 | 604 | 711 | 740 | 737 |
| Operating profit | 110 | 128 | 64 | 72 | 178 | 177 | 225 | 192 |
| OPM % | 14% | 18% | 9% | 10% | 23% | 20% | 23% | 21% |
| Other income | 9 | 8 | 15 | -77 | 21 | 15 | 67 | 31 |
| Interest | 73 | 60 | 48 | 48 | 55 | 60 | 50 | 52 |
| Depreciation | 55 | 55 | 53 | 56 | 53 | 65 | 53 | 55 |
| Profit before tax | -9 | 21 | -22 | -109 | 91 | 67 | 189 | 116 |
| Tax % | 78% | 5% | 105% | -1% | 10% | 9% | 13% | 8% |
| Net profit | -16 | 20 | -45 | -108 | 82 | 61 | 164 | 107 |
| EPS (₹) | -1.43 | 0.86 | -1.54 | -5.54 | 4.80 | 3.63 | 10.22 | 6.52 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Wockhardt Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 2,708 | 3,230 | 2,651 | 2,798 | 3,012 | 3,373 | 3,564 |
| Operating profit | -63 | 298 | 102 | 91 | 393 | 652 | 772 |
| OPM % | -2.3% | 9% | 3.9% | 3.2% | 13% | 19% | 22% |
| Net profit | 688 | -279 | -621 | -472 | -57 | 199 | 414 |
| EPS (₹) | 47.64 | -16.94 | -38.80 | -30.18 | -2.89 | 13.11 | 25.17 |
TTM is the trailing twelve months to the most recent quarter.
Wockhardt Ltd growth and returns
- 10 Years
- -3%
- 5 Years
- 4%
- 3 Years
- 8%
- TTM
- 18%
- 10 Years
- 1%
- 5 Years
- -19%
- 3 Years
- 43%
- TTM
- 983%
- 10 Years
- 10%
- 5 Years
- 38%
- 3 Years
- 103%
- 1 Year
- 31%
- 10 Years
- -2%
- 5 Years
- -3%
- 3 Years
- -1%
- Last Year
- 6%
Wockhardt Ltd shareholding pattern
Promoters held 49.09% at Jun 2026, broadly unchanged since Jun 2025. FIIs 7.23% and DIIs 9.24%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 51.99% | 49.09% | 49.09% | 49.09% | 49.09% | 49.09% | 49.09% | 49.09% |
| FIIs | 6.70% | 6.54% | 6.82% | 7.29% | 7.10% | 7.00% | 7.09% | 7.23% |
| DIIs | 5.08% | 9.82% | 10.58% | 11.00% | 11.00% | 10.55% | 10.96% | 9.24% |
| Government | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.04% | 0.02% |
| Public | 36.21% | 34.54% | 33.50% | 32.60% | 32.79% | 33.36% | 32.84% | 34.44% |
| No. of shareholders | 1,38,142 | 1,42,710 | 1,41,799 | 1,46,918 | 1,37,946 | 1,42,274 | 1,39,016 | 1,66,518 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Wockhardt Ltd corporate filings
- Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, the Proceedings of the 27th AGM of the CompanyAGM/EGMhigh impact
Cruxal's analysis: Wockhardt Limited has successfully concluded its 27th Annual General Meeting, securing…
Read the full analysis - Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICDR) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilisation ....Company Updatelow impact
Cruxal's analysis: Wockhardt Ltd has filed the Monitoring Agency Report issued by CRISIL Ratings Limited…
Read the full analysis - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseCompany Updatelow impact
Cruxal's analysis: Wockhardt Ltd has announced the launch of the 'Wockhardt Antibiotic Academy,' a platform…
Read the full analysis - Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026Company Updatehigh impact
Cruxal's analysis: Wockhardt Limited has delivered a robust performance for Q1 FY27, reporting a total…
Read the full analysis - Pursuant to Regulation 30 of SEBI Listing Regulations, Board of Directors at its meeting held today i.e 10th August, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) ....Board Meetinghigh impact
Cruxal's analysis: Wockhardt Limited has announced its unaudited financial results for the quarter ended 30…
Read the full analysis - Pursuant to Regulation 30 read with schedule III (Part A Para A) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find ....Company Updatelow impact
Cruxal's analysis: Wockhardt Ltd has released newspaper extracts regarding an addendum to the notice of its…
Read the full analysis - Addendum To The Notice Of 27Th Annual General Meeting Of The CompanyAGM/EGMlow impact
Cruxal's analysis: Wockhardt Limited has issued an addendum to its 27th Annual General Meeting notice…
Read the full analysis - Wockhardt Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1) of SEBI ....Board Meetinglow impact
Cruxal's analysis: Wockhardt Limited has announced that its Board of Directors will convene a meeting on…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Wockhardt Ltd
Cruxal reads every Wockhardt Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.